
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Japan), Japan, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
52%
Total
Publications
5.5K
Total Open
Publications
2.9K
Total
Citations
167K
Open Access
Percentage
52%
Total
Publications
5.5K
Total Open
Publications
2.9K
Total
Citations
167K
Breakdown
Publisher Open
23%
Both
24%
Other Platform Open
6%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
819
Hybrid 31%
801
No Guarantees 38%
977
Other Platform Open
Domain 74%
1.3K
Institution 42%
709
Other Internet 13%
227
Preprint 3%
50
Public 3%
50
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.3K |
doaj.org OAI-PMH Repository | Institution | 393 |
DOI | Other Internet | 166 |
Unknown Repository | Other Internet | 72 |
Europe PMC | Domain | 61 |
Figshare | Public | 46 |
National Institute of Informatics | Institution | 36 |
Royal Netherlands Academy of Arts and Sciences | Institution | 31 |
kuleuven.be OAI-PMH Repository | Institution | 25 |
University of Groningen | Institution | 22 |